arrow
C

Chen, Wei

nanjing medical university
H指数:0
被引数:1

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mitochondria-associated endoplasmic reticulum membranes: Emerging regulators of cardiac microvascular ischemia/reperfusion injury (Review)

王, Y.; 冯, B.; 吴, Y.; 孙, Z.; 袁H.; 陈, W.; 赵C.; 刘, Z. 线粒体相关内质网膜:心脏微血管缺血/再灌注损伤的新兴调控因子(综述)。Int. J. Mol. Med. 2026, 57, 34. [Google Scholar] [CrossRef]

2026-02-011
PRE
A Phase I/II Study Protocol of a Novel Neoadjuvant ‘PRaG’ Regimen (Radiotherapy, GM-CSF, and Cadonilimab) with AG Chemotherapy to Improve Resectability in Locally Advanced Pancreatic Ductal Adenocarcinoma: The NeoPRAG Study

一项新型新辅助‘PRaG’方案(放疗、GM-CSF和Cadonilimab)联合AG化疗以提高局部晚期胰腺导管腺癌可切除性的I/II期研究方案:NeoPRAG研究

2025-11-180
OA
Association between Textbook Outcomes of Liver Surgery and Overall Survival in Gallbladder Cancer Patients Treated with Curative-Intent Resection: A Multicenter Study

胆囊癌患者行根治性切除术治疗后,教科书式肝手术结局与总生存期的关联性:一项多中心研究

2025-09-010
PRE
Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway

更正:PARP1抑制剂与奥沙利铂联合应用,通过同源重组和碱基切除修复通路,高效抑制源自胃癌类器官的奥沙利铂耐药性。

2025-08-290
OA